IRIS
PELLEGRINO, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.582
AS - Asia 1.541
EU - Europa 825
SA - Sud America 258
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 4.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.520
SG - Singapore 608
CN - Cina 340
VN - Vietnam 295
BR - Brasile 197
IE - Irlanda 187
IT - Italia 152
HK - Hong Kong 133
SE - Svezia 125
DE - Germania 82
ZA - Sudafrica 70
FR - Francia 65
NL - Olanda 46
GB - Regno Unito 36
CA - Canada 32
AR - Argentina 27
AT - Austria 27
BD - Bangladesh 27
IN - India 22
FI - Finlandia 16
IQ - Iraq 16
RU - Federazione Russa 16
ES - Italia 15
MX - Messico 13
PL - Polonia 13
TR - Turchia 13
CI - Costa d'Avorio 12
PH - Filippine 12
EC - Ecuador 11
BE - Belgio 10
CZ - Repubblica Ceca 10
JP - Giappone 9
PK - Pakistan 8
ID - Indonesia 7
AL - Albania 6
EG - Egitto 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
KR - Corea 5
TN - Tunisia 5
TW - Taiwan 5
UZ - Uzbekistan 5
IL - Israele 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
AU - Australia 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LT - Lituania 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
CR - Costa Rica 2
DZ - Algeria 2
GH - Ghana 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
PS - Palestinian Territory 2
QA - Qatar 2
TH - Thailandia 2
UA - Ucraina 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MW - Malawi 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 4.324
Salva come PNG Salva come JPEG
Città #
Singapore 346
Ashburn 284
Dublin 186
Chandler 179
San Jose 164
Hong Kong 120
Santa Clara 113
Ho Chi Minh City 100
Beijing 99
Dallas 88
Hanoi 64
New York 64
Boardman 63
Johannesburg 61
Shanghai 56
Lauterbourg 37
Los Angeles 37
Vienna 24
Ann Arbor 23
São Paulo 23
Princeton 22
Bremen 21
Frankfurt am Main 21
Hefei 20
Seattle 20
Munich 17
Buffalo 14
Parma 14
Dearborn 13
Des Moines 13
Abidjan 12
Haiphong 12
Helsinki 12
Toronto 12
Brooklyn 10
Da Nang 10
Milan 10
Montreal 10
Nuremberg 10
Denver 9
Phoenix 9
Rome 9
Stockholm 9
Warsaw 9
Ardea 8
Atlanta 8
Baghdad 8
Brussels 8
Columbus 8
Moscow 8
Tokyo 8
Wilmington 8
Olomouc 7
Ravenna 7
Rio de Janeiro 7
Campinas 6
Reggio Emilia 6
Thái Nguyên 6
Tirana 6
Amsterdam 5
Bologna 5
Council Bluffs 5
Falls Church 5
London 5
Poplar 5
Rio Saliceto 5
Belo Horizonte 4
Biên Hòa 4
Cascina 4
Charlotte 4
City of London 4
Ha Long 4
Istanbul 4
Jakarta 4
Kunming 4
Madrid 4
Nanjing 4
Orem 4
Pavia 4
Shenzhen 4
Tashkent 4
The Dalles 4
Turku 4
Vũng Tàu 4
Alessandria 3
Ankara 3
Bexley 3
Boston 3
Brasília 3
Buenos Aires 3
Can Tho 3
Cape Town 3
Caracas 3
Chennai 3
Erbil 3
Fairfield 3
Guayaquil 3
Hangzhou 3
Houston 3
Huế 3
Totale 2.713
Salva come PNG Salva come JPEG
Nome #
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 168
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 161
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 157
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 153
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 153
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 150
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression 148
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 147
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 145
Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient 141
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 141
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 140
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 133
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 132
A review of immune checkpoint blockade in breast cancer 124
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review 123
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 121
My best choice after a round trip from illness 116
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 115
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 113
A narrative review of the principal glucocorticoids employed in cancer 113
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 112
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 107
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 105
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 104
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 100
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 99
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review 94
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 93
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification 90
Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients 88
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors 84
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review 84
PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors 81
The Innate Immune Microenvironment in Metastatic Breast Cancer 70
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 65
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 60
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 53
Totale 4.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.968
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202296 1 2 6 7 5 6 7 5 2 8 0 47
2022/2023652 49 66 33 48 70 71 4 47 214 4 38 8
2023/2024335 13 29 6 4 26 74 34 41 13 28 29 38
2024/2025955 36 40 59 52 113 98 53 42 122 87 73 180
2025/20262.153 220 188 258 213 269 133 207 76 318 190 81 0
Totale 4.383